TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features. - Wikidata - awgldk - TriplyDB

TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.

TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.

http://www.wikidata.org/entity/Q36147719

about

Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography.Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer.ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate.Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate Tumors Molecular classification of prostate cancer using curated expression signatures Isolation and characterization of circulating tumor cells in prostate cancer.Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry.Beyond PSA: the next generation of prostate cancer biomarkers.Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives.Diagnostic and prognostic molecular biomarkers for prostate cancer.Biomarkers for the diagnosis of new and recurrent prostate cancer.Androgen receptor gene rearrangements: new perspectives on prostate cancer progression New concepts concerning prostate cancer screening.Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer.The oncogene ERG: a key factor in prostate cancer.Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer.Prostate cancer in Jordanian-Arab population: ERG status and relationship with clinicopathologic characteristics.From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome.Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer.A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.ERG gene rearrangements are common in prostatic small cell carcinomas.Preliminary Results of Noninvasive Detection of TMPRSS2:ERG Gene Fusion in a Cohort of Patients With Localized Prostate Cancer ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer.Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients.Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer.Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers.Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas.Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels.Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis.Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.Molecular alterations associated with prostate cancer Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer

P2860

Q30240027-DE751E16-2C34-4338-B1C5-1CB54F2C6CED Q30573750-08467580-B2C6-468E-8406-215049564840 Q31005436-20CD715A-777F-4B24-84AA-B668CBBB7C69 Q35256427-E0DF96BE-1B52-4B6F-B9E0-F23D91CD2D70 Q35631603-97A2EEB0-FA29-4994-B644-3CF901E1E3D4 Q35641563-0058E301-3449-420D-8356-8DC4879C1181 Q36310363-A06492DA-18C1-4AC9-807D-5FF85BDE7724 Q36724548-4D6EA875-987D-4F42-8C10-2C7DED4F31AB Q37046014-3E2F183B-DC33-42DE-ACF1-223049B795E3 Q37238101-C4F9C183-0281-4BEB-AA58-83268807681A Q37947091-A15343C7-17D1-4DC7-A887-C687C5063CF3 Q37972703-4B7A752C-9352-48B2-9025-8883E78C69DC Q38052926-9D77F674-6B09-4096-8F21-8159FA2BC502 Q38081525-B4BFFEBD-4DDD-4EEB-80F6-8878DDC2F03E Q38220183-CF72C4D9-4066-4883-B9C1-5D450E6102FD Q38242279-3D4F64AA-7752-4486-9CB8-C367A9F29BB0 Q38444138-C6902306-0512-41FF-A58D-B02136B09243 Q38723072-C10076C0-E404-4EF6-95B6-4BF7283ECAA6 Q38760532-41F202C8-87F1-478E-904E-9BF2246E73A5 Q39354603-8F465CBC-ACCD-4BB7-8607-1003A37D6682 Q39457666-E86E0430-5AA5-4277-B851-2F5942A3FF1E Q39909790-098A0F21-10A1-44D9-A139-0BC7A9F8CBA5 Q39987660-78E9F583-F2AE-45CC-929E-56334D7D6B70 Q40028950-025759C5-B3EF-4AF1-BFB1-1D71F11A0343 Q40978920-D9B0D087-A6DA-4309-A2CD-A0F47BFF3150 Q41564129-4B8434CE-38BC-4A0C-A5B2-635188B102D5 Q41628946-7C07D035-D2D9-48C5-B908-5AF749421C74 Q41896226-E5AEEDCD-1E39-4E79-9D12-5CD9F901F3F1 Q41988183-45F1DDD5-4CDB-41F6-B141-484A3305D0F9 Q42287150-7E38605B-DAFF-44E6-92DC-29F20F63D2FA Q42350997-656D9D7D-F59D-4868-A544-C61A956E788C Q43684650-5C09AA1E-79A3-40A4-9341-B80517AA3599 Q43760304-09E5ADD8-BD36-4958-82C3-6E58BA517459 Q46265264-015D413B-6CAB-4438-8B2E-13BF1A5952E2 Q53519887-34708F5A-70D0-496F-A90C-A37512FA988D Q53801746-272D89C0-C76C-4317-AA26-F1DF62501278 Q54377548-933DB175-B401-43DC-A00B-D493408D68F5 Q57115048-DCC9246B-28A5-433B-A097-A6DD59EFDE89 Q57999041-9FEEE7CF-B1DD-4BF2-8D98-2A2FD8F51537 Q58701464-C30C8A3B-D326-465F-B742-F83828E3AC0B

P2860

TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.

http://www.wikidata.org/entity/Q36147719

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

TMPRSS2-ERG gene fusion is ass ...... -grade morphological features.

@ast

TMPRSS2-ERG gene fusion is ass ...... -grade morphological features.

@en

type

label

TMPRSS2-ERG gene fusion is ass ...... -grade morphological features.

@ast

TMPRSS2-ERG gene fusion is ass ...... -grade morphological features.

@en

prefLabel

TMPRSS2-ERG gene fusion is ass ...... -grade morphological features.

@ast

TMPRSS2-ERG gene fusion is ass ...... -grade morphological features.

@en

P1433

Q36147719-EA76E33F-76A4-401C-B637-AB437564D204

P1476

Q36147719-F3AFF729-CED7-4FA7-8B72-C620475D16D7

P2093

Q36147719-280C3AF4-5CB3-4108-B07C-84510C2EA140

Q36147719-34011A71-FBBC-4639-A58C-BED5B4B7DF10

Q36147719-7F406BAB-54E6-462B-A9B3-4594198F0F63

Q36147719-D110A325-F181-4CAC-9AA5-B73A84232C82

Q36147719-D3A67308-77FE-4679-9C46-EC383F353F9A

Q36147719-ED54E621-1084-4DCF-A76D-495AE9407923

Q36147719-F1B29FAB-5D7B-4225-BE41-6068254DC670

Q36147719-FAE6DB12-E59B-47D8-9A39-FD7895E89E84

P2860

Q36147719-081BD979-0B97-4842-A23D-56B8C6BE4F37

Q36147719-0D9AF951-89A2-4994-A620-ABFE364FB768

Q36147719-13787FB3-E498-434E-B7FD-24E25E942DE2

Q36147719-1A594316-74BE-45E1-954D-3BE50F02B4C8

Q36147719-1CDC70B9-380E-4174-A237-9AD31FED2D63

Q36147719-1F462DC0-37C3-4E34-94DB-AFBFFE8D6581

Q36147719-2F3BC5DA-2D09-41C8-8EDF-F0791290FEAD

Q36147719-2F6EF43C-5178-4275-80BE-0DA00587A3A1

Q36147719-3504227D-91D3-4A72-8256-516DC069B689

Q36147719-41B80521-FFC2-4735-88FC-D955B98D99CD

P2888

Q36147719-5D547217-E8C5-492F-8AEE-3D39066CB6D0

P304

Q36147719-1BE82B33-43B5-4FE4-A566-DBFB85427898

P31

Q36147719-7731DB9F-7EB9-40AE-A30D-070B0EAD9250

P356

Q36147719-6AEC093F-3403-4623-8A7A-459A6B9D0E4C

P433

Q36147719-74D36A8C-A7D7-4A06-8F1C-00BFAF2AFD28

P478

Q36147719-5ECB5B66-1DB4-45DF-9C80-84EEEFACFC82

P50

Q36147719-1D16DE2D-69E1-4679-B01E-B55C0C9058CB

Q36147719-83FD076A-D798-47C7-8359-41EF73AC010D

P577

Q36147719-6350B8DF-F78E-4D91-B82A-A86E52A610CF

P5875

Q36147719-333C42FA-819C-4D08-A3AE-D0945BEADC7D

P6179

Q36147719-F8C277C6-A0A7-43A9-BEE9-273AA90FB9B3

P698

Q36147719-9DBB8CD9-BF35-449D-94B5-89F9F21058E0

P932

Q36147719-3F537029-C523-4EF6-A834-535FBE8A3D7C

P356

MODPATHOL.2010.120

P1433

Modern Pathology

P1476

TMPRSS2-ERG gene fusion is ass ...... -grade morphological features.

@en

P2093

Anuradha Gopalan

http://www.w3.org/2001/XMLSchema#string

Margaret A Leversha

http://www.w3.org/2001/XMLSchema#string

Peter T Scardino

http://www.w3.org/2001/XMLSchema#string

Qin Zhou

http://www.w3.org/2001/XMLSchema#string

Samson W Fine

http://www.w3.org/2001/XMLSchema#string

Satish K Tickoo

http://www.w3.org/2001/XMLSchema#string

Victor E Reuter

http://www.w3.org/2001/XMLSchema#string

William L Gerald

http://www.w3.org/2001/XMLSchema#string

P2860

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

Natural history of progression after PSA elevation following radical prostatectomy.

Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

Mapping of genomic clones by fluorescence in situ hybridization.

Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.

Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy.

Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

P2888

modpathol.2010.120

P304

1325-1333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2010.120

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Hikmat Al-Ahmadie

P577

2010-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232797708

http://www.w3.org/2001/XMLSchema#string

P6179

1004027416

http://www.w3.org/2001/XMLSchema#string

P698

20562851

http://www.w3.org/2001/XMLSchema#string

P932

3413944

http://www.w3.org/2001/XMLSchema#string